
New drugs that could slow or prevent the start of dementia would be groundbreaking, but a new poll suggests many middle-aged adults may be reluctant to take part in the studies that test those medications. Only about 12% of the roughly 1,000 people aged 50 to 64 who were surveyed said they’re very likely to… read on > read on >